Jani; Rajni

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jani; Rajni.The latest application filed is for "aqueous pharmaceutical compositions containing borate-polyol complexes".

Company Profile

0.11.14

Jani; Rajni - Fort Worth TX
Jani; Rajni - Forth Worth TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aqueous Pharmaceutical Compositions Containing Borate-polyol Complexes App 20140294750 - Kabra; Bhagwati P. ; et al.	2014-10-02
Olopatadine formulations for topical nasal administration Grant 8,399,508 - Singh , et al. March 19, 2	2013-03-19
Olopatadine Formulations For Topical Nasal Administration App 20110306659 - Singh; Onkar N. ; et al.	2011-12-15
Olopatadine formulations for topical nasal administration Grant 7,977,376 - Singh , et al. July 12, 2	2011-07-12
Aqueous Pharmaceutical Compositions Containing Borate-polyol Complexes App 20090232763 - Kabra; Bhagwati P. ; et al.	2009-09-17
Use Of Steroids To Treat Persons Suffering From Ocular Disorders App 20090181933 - Bingaman; David P. ; et al.	2009-07-16
Self-Preserved Ophthalmic Pharmaceutical Compositions Containing Tobramycin App 20080089953 - Chowhan; Masood A. ; et al.	2008-04-17
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE App 20070173538 - Han; Wesley Wehsin ; et al.	2007-07-26
Olopatadine formulations for topical nasal administration App 20070142458 - Singh; Onkar N. ; et al.	2007-06-21
Use of steroids to treat ocular disorders App 20060154910 - Bingaman; David P. ; et al.	2006-07-13
Self-preserved ophthalmic pharmaceutical compositions containing tobramycin App 20060141059 - Chowhan; Masood A. ; et al.	2006-06-29
Formulations of glucocorticoids to treat pathologic ocular angiogenesis App 20060074061 - Bingaman; DavidP ; et al.	2006-04-06
Triamcinolone acetonide and anecortave acetate formulations for injection App 20050065137 - Jani, Rajni ; et al.	2005-03-24
Use of steroids to treat persons suffering from ocular disorders App 20040171598 - Bingaman, David P. ; et al.	2004-09-02
Formulations of glucocorticoids to treat pathologic ocular angiogenesis App 20040167109 - Bingaman, David P. ; et al.	2004-08-26
Use of an anti-allergy agent and a steroid to treat nasal conditions App 20040097474 - Cagle, Gerald D. ; et al.	2004-05-20
Antibacterial compositions Grant 5,679,336 - Ali , et al. October 21, 1	1997-10-21
Topical ophthalmic carbonic anhydrase inhibitor formulations Grant 5,620,970 - Han , et al. April 15, 1	1997-04-15
Compositions for treatment of glaucoma Grant 5,554,367 - Ali , et al. September 10, 1	1996-09-10
Intraocular irrigating solution containing agent for controlling IOP Grant 5,523,316 - Gan , et al. June 4, 1	1996-06-04
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions Grant 5,212,162 - Missel , et al. May 18, 1	1993-05-18
Anti-glaucoma compositions Grant 5,182,102 - DeSantis, Jr. , et al. January 26, 1	1993-01-26
Glaucoma formulations comprising an anionic, polysulfonic acid polymer having mucomimetic properties and a polystyrene sulfonic polymer Grant 5,093,126 - Jani , et al. * March 3, 1	1992-03-03
Sustained release, comfort formulation for glaucoma therapy Grant 4,911,920 - Jani , et al. March 27, 1	1990-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.